Basics Castle Biosciences, Inc. IPO Date: July 22, 2019 Sector: Healthcare Market Cap: $1.13B Activated in VL: True Average Daily Range Avg Daily Range: $0.99 | 2.98% Avg Daily Range (30 D): $0.74 | 2.38% Avg Daily Range (90 D): $0.57 | 2.31% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 1,369 Avg Inst. Trade: $1.3M Avg Inst. Trade (30 D): $1.65M Avg Inst. Trade (90 D): $1.44M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.39M Avg Closing Trade (30 D): $1.89M Avg Closing Trade (90 D): $1.48M Avg Closing Volume: 45.91K     News Nov 17, 2025 @ 12:00 PM Castle Biosciences Earns a Houston Chronicle Top W... Source: Derek Maetzold Nov 11, 2025 @ 12:00 PM Castle Biosciences to Present at the Piper Sandler... Source: Castle Biosciences Inc. Oct 26, 2025 @ 7:05 PM New Data at American College of Gastroenterology A... Source: Castle Biosciences, Inc. Oct 13, 2025 @ 11:00 AM Castle Biosciences to Release Third Quarter 2025 F... Source: Castle Biosciences Inc. Sep 17, 2025 @ 11:00 AM Castle Biosciences Named One of Newsweek’s ... Source: Castle Biosciences Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.02 $.16 Diluted EPS $-.02 $.15 Revenue $ $ 83.04M $ 86.19M Gross Profit $ $ 64.34M $ 68.56M Net Income / Loss $ $ -.5M $ 4.52M Operating Income / Loss $ $ -6.8M $ -4.25M Cost of Revenue $ $ 18.7M $ 17.63M Net Cash Flow $ $ 3.32M $ -7.46M PE Ratio